Former Pfizer CEO Kindler joins Lux Capital

By Staff Reporter

Aug 09, 2012 09:30 AM EDT

Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner, Lux said in a statement, where he will help scout for healthcare investment opportunities and work with portfolio companies.

Kindler retired from Pfizer in December 2010 after eight years with the company and was replaced as CEO by Ian Read.

Apart from his new role at Lux Capital, Kindler also serves on the board of several other pharmaceutical and healthcare companies. He is also a member of U.S. President Barack Obama's management advisory board and a director at private equity firm Starboard Capital Partners.

This article is copyrighted by Reuters

© 2024 VCPOST, All rights reserved. Do not reproduce without permission.

Join the Conversation

Real Time Analytics